RSCM
NDRM

Rock Springs Capital Management’s NeuroDerm Ltd. Ordinary Shares NDRM Stock Holding History

Rock Springs Capital Management’s Portfolio NDRM Stock Details NDRM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-237,700
Closed -$9.25M – 159
2017
Q3 		$9.25M Hold
237,700
– – 0.43% 75
2017
Q2 		$7.11M Buy
237,700
+153,621
+183% +$3.98M 0.36% 82
2017
Q1 		$2.23M Buy
+84,079
New +$2.08M 0.13% 119

Other funds holding NDRM

VOAM
Vertex One Asset Management Vancouver, British Columbia, Canada $434M AUM 37.82% 1-Year Est. Return
OTC
Opera Trading Capital Paris, France $419M AUM 0.58% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
FWM
Focused Wealth Management Newburgh, New York $1.15B AUM 24.81% 1-Year Est. Return

Rock Springs Capital Management's NDRM Position: Q4 2017 in Review

Rock Springs Capital Management sold out of NeuroDerm Ltd. Ordinary Shares (NDRM) in Q4 2017, closing a stake of 237,700 shares — an estimated $9.25M sold.

Rock Springs Capital Management first reported a position in NDRM in Q1 2017 and held it in 3 quarters. The position peaked at $9.25M in Q3 2017. 5 funds tracked by Wall St. Rank hold NDRM as of Q4 2017.

  • Rock Springs Capital Management reported no remaining NeuroDerm Ltd. Ordinary Shares position as of Q4 2017 after selling out during the quarter.
  • Rock Springs Capital Management sold 237,700 NeuroDerm Ltd. Ordinary Shares shares in Q4 2017, an estimated $9.25M.
  • Rock Springs Capital Management first reported a position in NeuroDerm Ltd. Ordinary Shares in Q1 2017 and held it in 3 quarters.
  • Rock Springs Capital Management's NeuroDerm Ltd. Ordinary Shares position peaked at $9.25M in Q3 2017.
  • 5 funds tracked by Wall St. Rank held NeuroDerm Ltd. Ordinary Shares as of Q4 2017.

Based on Rock Springs Capital Management's 13F filing for Q4 2017, filed 14 Feb 2018.